Overdetection in screening for prostate cancer.

Overdetection in screening for prostate cancer.

Item
http://www.wikidata.org/entity/Q38199582
The ProCaSP study: quality of life outcomes of prostate cancer patients after radiotherapy or radical prostatectomy in a cohort study.Active surveillance for prostate cancer: a legal perspectiveSocioeconomic determinants of prostate-specific antigen testing and estimation of the prevalence of undiagnosed prostate cancer in an elderly Polish population based on the PolSenior studyBiomarkers for prostate cancer: present challenges and future opportunities.Implementation of Multi-parametric Prostate MRI in Clinical Practice.Serum metabolomics can predict the outcome of first systematic transrectal prostate biopsy in patients with PSA <10 ng/ml.Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer.Prostate imaging--the future is now: current concepts and future potentials.[Is Grail's goal feasible?].Active surveillance review: contemporary selection criteria, follow-up, compliance and outcomes.Multidisciplinary Approach of Prostate Cancer Patients
P2860

Overdetection in screening for prostate cancer.

Item
http://www.wikidata.org/entity/Q38199582
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Overdetection in screening for prostate cancer.
@en
type
label
Overdetection in screening for prostate cancer.
@en
prefLabel
Overdetection in screening for prostate cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Overdetection in screening for prostate cancer.
@en
P2093
P304
P31
P356
10.1097/MOU.0000000000000054
P433
P478
P577
P698